Neurol. praxi. 2009;10(5):297-299

Intrathecal synthesis of specific antiviral antibodies in relapsing-remitting and primary chronic progressive courses of multiple sclerosis

MUDr. Jana Bednářová, Ph.D1, doc. MUDr. Pavel Štourač, Ph.D2
1 Biochemické oddělení Fakultní nemocnice Brno
2 Neurologická klinika LF MU a FN u sv. Anny, Brno

The relapsing-remitting and primary chronic progressive courses are distinguished in cerebrospinal multiple sclerosis. Both these types

differ in the pathogenesis, immunology, therapeutic response, and prognosis. No laboratory diagnostic marker to distinguish these two

disease subentities has been available to date. Our aim was to assess the intrathecal synthesis of specific IgG antibodies against the neurotropic

measles, rubella, and herpes zoster viruses (the MRZ reaction) in the relapsing-remitting course and primary chronic progressive

course and to establish its differential diagnostic significance. A cohort of 35 patients (n = 35) was investigated. The intrathecal synthesis of

specific antibodies was expressed by the antibody index using Reiber‘s formula. The MRZ reaction was positive in 14 out of 25 patients with

the relapsing-remitting course and in 2 out of 10 patients with the primary chronic progressive course of multiple sclerosis with sensitivities

of 56 % and 20 %, respectively. The difference in the positivity of the MRZ reaction in both the courses supports the hypothesis of different

pathogeneses, suggesting that the MRZ reaction may be used as a complementary marker in differential diagnosis.

Keywords: cerebrospinal multiple sclerosis, relapsing-remitting course, primary chronic progressive course, intrathecal synthesis, MRZ reaction.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bednářová J, Štourač P. Intrathecal synthesis of specific antiviral antibodies in relapsing-remitting and primary chronic progressive courses of multiple sclerosis. Neurol. praxi. 2009;10(5):297-299.
Download citation

References

  1. Anderson M, Alverez-Cermeno J, Bernardi G, Cogato I, Fredman P, Frederiksen S, Gallo P, Grimaldi LM, Gronning M. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatr 1994; 57: 897-902. Go to original source... Go to PubMed...
  2. Annunziata P, Giorgio A, De Santi L, Zipoli V, Portaccio E, Amato MP, Clerici R, Scarpini E, Moscato G, Iudice A, Vacca G, Orefice G, Morra VB, Maimone D. Absence of cerebrospinal fluid bands is associated with delayed progression in relapsing-remitting MS patients treated with interferon - beta. J Neurol Sci 2006; 244: 97-102. Go to original source... Go to PubMed...
  3. Bednářová J, Štourač P, Krbková L. The diagnostic significance of intrathecal occurence of selected antiviral antibodies in multiple sclerosis. Scripta Medica 2005; 78(4): 249-254.
  4. Felgenhauer K, Reiber H. The diagnostic significance of antibody specificity indices in multiple sclerosis and herpes virus induced diseases of the nervous system. Clin Invest 1992; 70: 28-37. Go to original source... Go to PubMed...
  5. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Ohman S, Racke MK, Sharief M, Sindic CJ, Sellebjerg F, Tourtellotte WW. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Arch Neurol 2005; 865-870. Go to original source... Go to PubMed...
  6. Graef IT, Henze T, Reiber H. Polyspezifische Immunreaktion in ZNS bei Autoimmunerkrankung mit ZNS Beteiligung. Zeitschrift fur Artztl Fortbildung 1994; 88: 587-591.
  7. Link H, Tibbling G. Principles of albumin and IgG analysis in neurological disorders III. Validation of IgG synthesis within the central nervous system in multiple sclerosis. Scan J Clin Lab Invest 1977; 37: 397-401. Go to original source...
  8. Polman CH, Reingold S, Edan G, Filippi M, Hartung HP, Kappos L, Lublin F, Metz L, McFarland H, O'Connor P, SandbergWollheim M, Thompson A, Weinshenker B, Wolinsky J. Diagnostic Criteria for Multiple Sclerosis: 2005 Revisions to the, ,McDonald Criteria". Ann Neurol 2005; 58: 840-846. Go to original source... Go to PubMed...
  9. Reiber H, Lange P. Quantification of virus specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clinical Chemistry 1991; 37: 1153-1160. Go to original source...
  10. Reiber H, Peter JB. Cerebrospinal fluid analysis: disease - related data patterns and evaluation programs. J Neurol Sci 2001; 2: 101-122. Go to original source... Go to PubMed...
  11. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998; 4: 111-117. Go to original source... Go to PubMed...
  12. Tumani H, Noelker G, Reiber H. Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 1995; 45: 1663-1670. Go to original source... Go to PubMed...
  13. Zeman AZJ, Kidd J, McLean BN. A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatr 1996; 60: 27-30. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.